Recombinant human TRAIL-R1 (DR4)/Fc Chimera

Recombinant human TRAIL-R1 (DR4)/Fc Chimera
Regulatory status
RUO
Format
Purified
Reactivity
Human
Application
Variant
0.05 mg
EXB0006
In stock
290.00 USD
Variant
0.1 mg
11-261-C100
In stock
290.00 USD
Product details
Images
Application
Reactivity
Human
Description
Recombinant human TRAIL-R1 (DR4)/Fc Chimera protein is produced in HEK 293 cells. The extracellular domain of human TRAIL-R1 (aa 1 -238) is fused to the Fc portion of human IgG1.
A calculated molecular mass of fusion protein is 43 kDa. As a result of glycosylation, the recombinant protein migrates approximately as a 46 kDa protein in SDS-PAGE under reducing conditions.
Contents
Recombinant human TRAIL-R1 (DR4)/Fc Chimera - 1 vial (0.05 mg).
Reconstitute vial content with 50 μl sterile deionized water.
For long term storage or for preparation of more diluted working stock solution, a carrier protein (e.g. 1% serum albumin) should be added to the vial.
Preparation
Purified by protein-A affinity chromatography. Lyophilized from a 0.2 μm filtered solution in Storage buffer (PBS, pH 7.4).
Storage and handling
Store at -20°C to -80°C. Reconstitute in sterile deionized water. Use reconstituted product immediately or aliquot for further storage at -20°C to -80°C.
Exbio licence note
Unless indicated otherwise, all products are For Research Use Only and not for diagnostic use. In vivo diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s. © 2019 EXBIO Praha, a.s. All rights reserved.
EXB0006_WB_2
Western blotting of TRAIL-R1 (DR4) / Fc recombinant protein. Reducing conditions. Lane 1 to 5: Immunostaining with TRAIL-R1 (DR4) specific antibody DR-4-02 (Cat. No. 10-403-C100; dilution 2 μg/ml ). Detection with Goat anti-mouse / HRP secondary antibody. Amount of TRAIL-R1 (DR4)/ Fc recombinant protein loaded on each lane: (1) 370 ng, (2) 150 ng, (3) 75 ng, (4) 37 ng, (5) 15 ng.
EXB0006_WB_1
SDS-PAGE Electrophoresis of TRAIL-R1 (DR4) / Fc recombinant protein (12% separating gel; reducing conditions). Lane 1 to 3: TRAIL-R1 (DR4)/ Fc recombinant protein (2000 ng, 1000 ng, 500 ng per lane). Staining with Coomassie Blue.
Variant
0.05 mg
EXB0006
In stock
290.00 USD
Variant
0.1 mg
11-261-C100
In stock
290.00 USD

Related products

-134%
CloneDR-4-02
Reg. statusRUO
ApplicationFC, IP, ICC
0.1 mg
180.00 USD